Leiomyosarcoma Masquerading as Bowel Obstruction: A Rare and Lethal Entity
Document Type
Conference Proceeding
Publication Date
11-2025
Publication Title
American Journal of Clinical Pathology
Abstract
Introduction/Objective: Leiomyosarcoma (LMS) of the gastrointestinal tract (GIT) is an aggressive malignancy often presenting as bowel obstruction. Its vague symptoms and limited accessibility frequently delay diagnosis. Unlike gastrointestinal stromal tumors (GISTs), LMS lacks effective targeted therapy, making complete surgical resection the primary treatment option. Methods/Case Report: Case 1: An 89-year-old male presented with acute abdominal pain. CT imaging revealed a 9 × 5 cm exophytic mass causing small bowel obstruction. Laparotomy identified a large, well-circumscribed jejunal mass with bowel twisting and obstruction. Segmental small bowel resection was performed. Pathologic examination confirmed a LMS. Case 2: An 81-year-old male presented with acute abdominal pain. CT and laparotomy revealed a cecal mass with obstruction. The patient underwent right hemicolectomy. Pathologic examination showed a moderate to poorly differentiated LMS. Immunohistochemistry in both cases was positive for desmin and SMA, and negative for CD34, CD117, and S100, differentiating LMS from GIST. Although the postoperative course was uneventful, the first patient (case 1) succumbed six months later, emphasizing the aggressive nature of LMS. Results: NA Conclusion: Despite an uneventful postoperative course, the first patient succumbed six months later, highlighting LMS’s aggressive nature. These cases emphasize the diagnostic and therapeutic challenges of LMS, underscoring the need for heightened clinical aware - ness and multidisciplinary approaches for better patient outcomes.
Volume
164
Issue
Suppl 1
First Page
S47
Last Page
S47
Recommended Citation
Gaddam S, Khan S, Jabbar K, Nasir A, Arora K. Leiomyosarcoma masquerading as bowel obstruction: a rare and lethal entity. Am J Clin Pathol. 2025 Nov;164(Suppl 1):S47. doi:10.1093/ajcp/aqaf121.112
DOI
10.1093/ajcp/aqaf121.112

Comments
American Society for Clinical Pathology (ASCP) Annual Meeting, November 17-20, 2025, Atlanta, GA